Search

Start Over Keyword IMMUNE-RESPONSES

  • Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice

    Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
    Authors:Bo Ryoung Park, Georgia State UniversityRamireddy Bommireddy, Emory UniversityDavid Hyunjung Chung, Georgia State UniversityKi-Hye Kim, Georgia State UniversityJeeva Subbiah, Georgia State UniversityYu-Jin Jung, Georgia State UniversityNoopur Bhatnagar, Georgia State UniversityChristopher D Pack, Metaclipse Therapeutics Corporation, AtlantaSampath Ramachandiran, Metaclipse Therapeutics Corporation, AtlantaShaker JC Reddy, Metaclipse Therapeutics Corporation, AtlantaPeriasamy Selvaraj, Emory UniversitySang-Moo Kang, Georgia State University
    Date:2023
    Publisher:BMC
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral control

    Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral control
    Authors:Jaisheela Vimali, Central University of Tamil NaduYean Kong Yong, Xiamen University MalaysiaAmudhan Murugesan, Government Theni Medical College and HospitalKumaran Vishnupriya, Central University of Tamil NaduRajeev Ashwin, Central University of Tamil NaduEvangeline Ann Daniel, Indian Council of Medical ResearchPachamuthu Balakrishnan, Saveetha Inst Med & Tech Sci SIMATSSivadoss Raju, Directorate of Public Health and Preventive MedicineMohamed Rosmawati, Universiti Malaya Medical CenterVijayakumar Velu, Emory UniversityMarie Larsson, Linkoping UniversityEsaki M Shankar, Central University of Tamil Nadu
    Date:2022
    Publisher:FRONTIERS MEDIA SA
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model

    A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
    Authors:Vasilis C Pliasas, Auburn UniversityZach Menne, Emory UGA Ctr Excellence Influenza Res & SurveillaVirginia Aida, Auburn UniversityJi-Hang Yin, Auburn UniversityMaria C Naskou, Auburn UniversityPeter J Neasham, Auburn UniversityFletcher J North, Auburn UniversityDylan Wilson, Auburn UniversityKatharine A Horzmann, Auburn UniversityJoshy Jacob, Emory UniversityIoanna Skountzou, Emory UniversityConstantinos S Kyriakis, Auburn University
    Date:2022
    Publisher:FRONTIERS MEDIA SA
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette

    Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette
    Authors:Sandeep RP Kumar, Indiana UniversityJun Xie, University of Massachusetts WorcesterShilang Hu, University of Massachusetts WorcesterJihye Ko, University of Massachusetts WorcesterQifeng Huang, University of Massachusetts WorcesterHarrison C Brown, Expression TherapeuticsAlok Srivastava, Christian Medical College and Centre for Stem Cell ResearchDavid M Markusic, Indiana UniversityChristopher Doering, Emory UniversityH Trent Spencer, Emory UniversityArun Srivastava, University of FloridaGuangping Gao, University of Massachusetts WorcesterRoland W Herzog, Indiana University
    Date:2021
    Publisher:CELL PRESS
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

    Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
    Authors:Joseph R Francica, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBarbara J Flynn, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaKathryn E Foulds, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAmy T Noe, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAnne P Werner, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaIan Moore, Emory UniversityMatthew Gagne, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaTimothy S Johnston, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaCourtney Tucker, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaRachel L Davis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBritta Flach, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaSarah O'Connell, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaShayne F Andrew, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaEvan Lamb, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDillon R Flebbe, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaSaule T Nurmukhambetova, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMitzi M Donaldson, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaJohn-Paul M Todd, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAlex Lee Zhu, MITCaroline Atyeo, MITStephanie Fischinger, MITMatthew J Gorman, MITSally Shin, MITVenkata Viswanadh Edara, Childrens Healthcare Atlanta & Emory UnivKatharine Floyd, Childrens Healthcare Atlanta & Emory UnivLilin Lai, Emory UniversitySeyhan Boyoglu-Barnum, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaRenee Van de Wetering, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAlida Tylor, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaElizabeth McCarthy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaValerie Lecouturier, Sanofi PasteurSophie Ruiz, Sanofi PasteurCatherine Berry, Sanofi PasteurTimothy Tibbitts, Sanofi PasteurHanne Andersen, BIOQUAL Inc.Anthony Cook, BIOQUAL Inc.Alan Dodson, BIOQUAL Inc.Laurent Pessaint, BIOQUAL Inc.Alex Van Ry, BIOQUAL Inc.Marguerite Koutsoukos, GSKCindy Gutzeit, GSKI-Ting Teng, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaTongqing Zhou, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDapeng Li, Duke UniversityBarton F Haynes, Duke UniversityPeter D Kwong, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaAdrian McDermott, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMark G Lewis, BIOQUAL Inc.Tong Ming Fu, Sanofi PasteurRoman Chicz, Sanofi PasteurRobert van der Most, GSKKizzmekia S Corbett, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMehul Suthar, Emory UniversityGalit Alter, MITMario Roederer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaNancy J Sullivan, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDaniel C Douek, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaBarney S Graham, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaDanilo Casimiro, Sanofi PasteurRobert A Seder, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
    Date:2021
    Publisher:AMER ASSOC ADVANCEMENT SCIENCE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine

    Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine
    Authors:Oluwaseyi Adekunle, Emory UniversityAlexandra Dretler, Emory UniversityRobert C Kauffman, Emory UniversityAlice Cho, Emory UniversityNadine Rouphael, Emory UniversityJens Wrammert, Emory University
    Date:2021
    Publisher:PUBLIC LIBRARY SCIENCE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial

    Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial
    Authors:Nadine Rouphael, Emory UniversityLilin Lai, Emory UniversitySonia Tandon, Emory UniversityMichele Paine McCullough, Emory UniversityYuchuan Kong, Emory UniversitySarah Kabbani, Emory UniversityMuktha S Natrajan, Emory UniversityYongxian Xu, Emory UniversityYerun Zhu, Emory UniversityDongli Wang, Emory UniversityJesse O'Shea, Emory UniversityAmy Sherman, Emory UniversityTianwei Yu, Emory UniversitySebastien Henry, Micron Biomedical, Inc.Devin McAllister, Micron Biomedical, Inc.Daniel Stadlbauer, Icahn School of Medicine at Mount SinaiSurender Khurana, US FDAHana Golding, US FDAFlorian Krammer, Icahn School of Medicine at Mount SinaiMark Mulligan, Emory UniversityMark Prausnitz, Emory University
    Date:2021
    Publisher:NATURE PORTFOLIO
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV

    A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV
    Authors:Alex J Warr, University of WashingtonChristine Anterasian, University of WashingtonJaveed A Shah, University of WashingtonStephen C De Rosa, Fred Hutchinson Cancer Research CenterFelicia K Nguyen, University of WashingtonElizabeth Maleche-Obimbo, University of NairobiLisa Cranmer, Emory UniversityDaniel Matemo, Kenyatta National HospitalJerphason Mecha, Kenyatta National HospitalJohn Kinuthia, Kenyatta National HospitalSylvia M LaCourse, University of WashingtonGrace C John-Stewart, University of WashingtonThomas R Hawn, University of Washington
    Date:2022
    Publisher:ELSEVIER
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies

    Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies
    Authors:Robert C Kauffman, Emory UniversityOluwaseyi Adekunle, Emory UniversityHanyi Yu, Emory UniversityAlice Cho, Emory UniversityLindsay E Nyhoff, Emory UniversityMeagan Kelly, Massachusetts General HospitalJason B Harris, Harvard Medical SchoolTaufiqur Rahman Bhuiyan, International Centre for Diarrhoeal Disease ResearchFirdausi Oadri, International Centre for Diarrhoeal Disease ResearchStephen B Calderwood, Massachusetts General HospitalRichelle C Charles, Massachusetts General HospitalEdward T Ryan, Massachusetts General HospitalJun Kong, Emory UniversityJens Wrammert, Emory University
    Date:2021
    Publisher:AMER SOC MICROBIOLOGY
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Distinct transcriptome profiles of Gag-specific CD8+T cells temporally correlated with the protection elicited by SIV Delta nef live attenuated vaccine

    Distinct transcriptome profiles of Gag-specific CD8+T cells temporally correlated with the protection elicited by SIV Delta nef live attenuated vaccine
    Authors:Wuxun Lu, University of NebraskaYanmin Wan, University of NebraskaFangrui Ma, University of NebraskaR. Paul Johnson, Emory UniversityQinghseng Li, University of Nebraska
    Date:2017
    Publisher:PUBLIC LIBRARY SCIENCE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International